2. Academic Validation
  3. Design and synthesis of selective, high-affinity inhibitors of human cytochrome P450 2J2

Design and synthesis of selective, high-affinity inhibitors of human cytochrome P450 2J2

  • Bioorg Med Chem Lett. 2006 May 15;16(10):2777-80. doi: 10.1016/j.bmcl.2006.02.004.
Pierre Lafite 1,  Sylvie Dijols,  Didier Buisson,  Anne-Christine Macherey,  Darryl C Zeldin,  Patrick M Dansette,  Daniel Mansuy
Affiliations

Affiliation

  • 1 Laboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques, UMR 8601 CNRS, Universite Paris 5 René Descartes, 45 Rue des Saints-Pères, 75270 Paris Cedex 06, France.
PMID: 16495056 DOI: 10.1016/j.bmcl.2006.02.004
Abstract

The active site topology, substrate specificity, and biological roles of the human Cytochrome P450 CYP2J2, which is mainly expressed in the cardiovascular system, are poorly known even though recent data suggest that it could be a novel biomarker and potential target for therapy of human Cancer. This paper reports a first series of high-affinity, selective CYP2J2 inhibitors that are related to terfenadine, with K(i) values as low as 160nM, that should be useful tools to determine the biological roles of CYP2J2.

Figures